Actively Recruiting
Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty
Led by Connecticut Children's Medical Center · Updated on 2025-05-29
128
Participants Needed
2
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main question this randomized control trial aims to answer is: • Is the use of intraoperative subpectoral bupivacaine associated with decreased post-operative pain in adolescent patients who undergo bilateral reduction mammaplasty Participants will be randomized into the study group that intraoperatively receives 30cc of subpectoral bupivacaine injections or into the control group that intraoperatively receives 30cc of injectable saline subpectorally. All participants will keep a pain log and pain medication log at home for the first week following surgery. Researchers will compare to see if patients who receive subpectoral bupivacaine have lower pain scores in the PACU, and lower use of narcotics post-operatively when compared to the control group who receive injectable saline.
CONDITIONS
Official Title
Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female
- Age 13 to 25 years at the time of surgery
- Undergoing bilateral reduction mammaplasty at Connecticut Children's between 1/1/2022 and 12/31/2025
- Parent or legal guardian able to understand and willing to sign informed consent
You will not qualify if you...
- History of substance use disorder or chronic pain requiring pain specialist management
- Currently taking narcotics at time of surgery
- History of liver or kidney dysfunction
- Known allergy to bupivacaine
- Pregnancy confirmed by urine test before surgery
- Non-verbal or developmental delays preventing reliable pain reporting
- Significant post-operative complications
- Not meeting the inclusion criteria
- Lost to follow-up before 1 and 4 week post-operative visits
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Connecticut Children's
Farmington, Connecticut, United States, 06032
Actively Recruiting
2
Connecticut Children's
Hartford, Connecticut, United States, 06106
Actively Recruiting
Research Team
L
Lauren C Schmidtberg, PA-C
CONTACT
C
Christopher Hughes, MD, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here